Form 8-K RAPT Therapeutics, Inc. For: May 23
http://archive.fast-edgar.com/20220523/AN223G2DZZ2RAZZU22JH2ZYPBNDSOZ22Z242
Filed on: May 23, 2022
Form 8-K Triumph Bancorp, Inc. For: May 23
http://archive.fast-edgar.com/20220523/ALZZ222COC2272BP222Q22Z2O5INZ22IZ442
Filed on: May 23, 2022
Form D TIDAL PETROLEUM INC
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 4 Hall of Fame Resort & For: May 19 Filed by: Lee Benjamin J
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 8-K Seagen Inc. For: May 23
Exhibit 99.1
Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combination With Trastuzumab in HER2-Positive Metastatic Colorectal Cancer
- Data Accepted for Presentation at ESMO World Congress on Gastrointestinal Cancer -
BOTHELL, Wash.--May 23, 2022Seagen Inc. (Nasdaq:SGEN) today announced positive topline results from the pivotal phase 2 MOUNTAINEER clinical trial investigating TUKYSA® (tucatinib)... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B3 indie Semiconductor,
-
Form 8-K COLONY BANKCORP INC For: May 23
-
Form 424B3 indie Semiconductor,
-
Form 8-K INSMED Inc For: May 23
-
Form 6-K Enlivex Therapeutics For: May 23
-
Form 6-K CANADIAN NATIONAL RAILWA For: May 20
-
Form 8-K STAR EQUITY HOLDINGS, For: May 23
-
Form 8-K Tiga Acquisition Corp. For: May 20
-
Form 8-K GLAUKOS Corp For: May 23
-
Form 424B3 WOODSIDE ENERGY GROUP
-
Form 8-K OWENS & MINOR INC/VA/ For: May 23
-
Form DEF 14A Centessa Pharmaceuticals For: Jun 30
-
Form DEFA14A Jaguar Health, Inc.
-
Form DEF 14A SmartKem, Inc. For: Jun 30
-
Form 6-K CANADIAN NATIONAL RAILWA For: May 20
-
Form 8-K AGILE THERAPEUTICS INC For: May 20
-
Form 10-Q UpHealth, Inc. For: Mar 31
-
Form 8-K Invesco Real Estate Inco For: May 23
-
Form 6-K RYANAIR HOLDINGS PLC For: May 23
-
Form 6-K Cellectis S.A. For: May 23
-
Form D GREEN SWAFFORD & WITTROC
-
Form 6-K Secoo Holding Ltd For: May 23
-
Form 10-Q Dream Homes & Developmen For: Mar 31
-
Form 8-K PARSONS CORP For: May 23
-
Form 8-K AT&T INC. For: May 20
-
Form 10-Q CANNAPHARMARX, INC. For: Mar 31
-
Form SC 13G HIRU Corp Filed by: Mina Mar Corp
-
Form 8-K ClearPoint Neuro, Inc. For: May 23
-
Form 10-Q NUNZIA PHARMACEUTICAL For: Mar 31
-
Form 8-K CHINA AUTOMOTIVE SYSTEMS For: May 23
-
Form 10-Q Kisses From Italy Inc. For: Mar 31
-
Form 424B2 Eos Energy Enterprises,
-
Form 6-K uCloudlink Group Inc. For: May 23
-
Form 8-K CareDx, Inc. For: May 18
-
Form 8-K FIRSTENERGY CORP For: May 17
-
Form S-3ASR Reynolds Consumer Produc
-
Form D Fulcrum Funds SPC - Fulc
-
Form 13F-HR Spartan Fund Management For: Mar 31
-
Form SC 13D/A MAGIC SOFTWARE ENTERPRIS Filed by: FORMULA SYSTEMS (1985) LTD
-
Form 8-K CONCERT PHARMACEUTICALS, For: May 23
-
Form 10-Q Heliogen, Inc. For: Mar 31
-
Form 6-K So-Young International For: May 23
-
Form 8-K Heliogen, Inc. For: May 23
-
Form 6-K PolyPid Ltd. For: May 23
-
Form 8-K JOINT Corp For: May 19
-
Form 4 RumbleOn, Inc. For: May 20 Filed by: Levy Peter
-
Form 6-K GILAT SATELLITE NETWORKS For: May 23
-
Form 8-K NEXTERA ENERGY INC For: May 19
-
Form 4 RumbleOn, Inc. For: May 20 Filed by: Marchlik Michael
-
Form 8-K KAMAN Corp For: May 21